TY - JOUR
T1 - An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
AU - Vacca, Michele
AU - Kamzolas, Ioannis
AU - Harder, Lea Mørch
AU - Oakley, Fiona
AU - Trautwein, Christian
AU - Hatting, Maximilian
AU - Ross, Trenton
AU - Bernardo, Barbara
AU - Oldenburger, Anouk
AU - Hjuler, Sara Toftegaard
AU - Ksiazek, Iwona
AU - Lindén, Daniel
AU - Schuppan, Detlef
AU - Rodriguez-Cuenca, Sergio
AU - Tonini, Maria Manuela
AU - Castañeda, Tamara R.
AU - Kannt, Aimo
AU - Rodrigues, Cecília M.P.
AU - Cockell, Simon
AU - Govaere, Olivier
AU - Daly, Ann K.
AU - Allison, Michael
AU - Honnens de Lichtenberg, Kristian
AU - Kim, Yong Ook
AU - Lindblom, Anna
AU - Oldham, Stephanie
AU - Andréasson, Anne Christine
AU - Schlerman, Franklin
AU - Marioneaux, Jonathon
AU - Sanyal, Arun
AU - Afonso, Marta B.
AU - Younes, Ramy
AU - Amano, Yuichiro
AU - Friedman, Scott L.
AU - Wang, Shuang
AU - Bhattacharya, Dipankar
AU - Simon, Eric
AU - Paradis, Valérie
AU - Burt, Alastair
AU - Grypari, Ioanna Maria
AU - Davies, Susan
AU - Driessen, Ann
AU - Yashiro, Hiroaki
AU - Pors, Susanne
AU - Worm Andersen, Maja
AU - Feigh, Michael
AU - Yunis, Carla
AU - Bedossa, Pierre
AU - Stewart, Michelle
AU - van Mil, Saskia
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/6
Y1 - 2024/6
N2 - Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease, encompasses steatosis and metabolic dysfunction-associated steatohepatitis (MASH), leading to cirrhosis and hepatocellular carcinoma. Preclinical MASLD research is mainly performed in rodents; however, the model that best recapitulates human disease is yet to be defined. We conducted a wide-ranging retrospective review (metabolic phenotype, liver histopathology, transcriptome benchmarked against humans) of murine models (mostly male) and ranked them using an unbiased MASLD ‘human proximity score’ to define their metabolic relevance and ability to induce MASH-fibrosis. Here, we show that Western diets align closely with human MASH; high cholesterol content, extended study duration and/or genetic manipulation of disease-promoting pathways are required to intensify liver damage and accelerate significant (F2+) fibrosis development. Choline-deficient models rapidly induce MASH-fibrosis while showing relatively poor translatability. Our ranking of commonly used MASLD models, based on their proximity to human MASLD, helps with the selection of appropriate in vivo models to accelerate preclinical research.
AB - Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease, encompasses steatosis and metabolic dysfunction-associated steatohepatitis (MASH), leading to cirrhosis and hepatocellular carcinoma. Preclinical MASLD research is mainly performed in rodents; however, the model that best recapitulates human disease is yet to be defined. We conducted a wide-ranging retrospective review (metabolic phenotype, liver histopathology, transcriptome benchmarked against humans) of murine models (mostly male) and ranked them using an unbiased MASLD ‘human proximity score’ to define their metabolic relevance and ability to induce MASH-fibrosis. Here, we show that Western diets align closely with human MASH; high cholesterol content, extended study duration and/or genetic manipulation of disease-promoting pathways are required to intensify liver damage and accelerate significant (F2+) fibrosis development. Choline-deficient models rapidly induce MASH-fibrosis while showing relatively poor translatability. Our ranking of commonly used MASLD models, based on their proximity to human MASLD, helps with the selection of appropriate in vivo models to accelerate preclinical research.
UR - http://www.scopus.com/inward/record.url?scp=85195930089&partnerID=8YFLogxK
U2 - 10.1038/s42255-024-01043-6
DO - 10.1038/s42255-024-01043-6
M3 - Article
C2 - 38867022
AN - SCOPUS:85195930089
VL - 6
SP - 1178
EP - 1196
JO - Nature Metabolism
JF - Nature Metabolism
IS - 6
ER -